Mark A Harris Selected Research

Captan

1/2020	An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
10/2019	Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome Pathway.
12/2017	Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Harris Research Topics

Disease

22	Neoplasms (Cancer) 01/2020 - 01/2011
11	Hyperplasia 01/2020 - 09/2011
9	Carcinogenesis 10/2019 - 09/2011
4	Intestinal Neoplasms (Intestinal Cancer) 10/2019 - 05/2014
1	Iron Deficiencies 03/2014
1	Anemia 03/2014
1	Carcinoma (Carcinomatosis) 03/2013
1	Adenoma (Adenomas) 03/2013
1	Inflammation (Inflammations) 01/2011

Drug/Important Bio-Agent (IBA)

23	chromium hexavalent ionIBA 01/2020 - 01/2011
15	Drinking WaterIBA 01/2018 - 01/2011
3	CaptanIBA 01/2020 - 12/2017
3	folpet (Phaltan)IBA 01/2020 - 12/2017
3	CarcinogensIBA 10/2019 - 01/2011
3	sodium bichromate (sodium dichromate)IBA 06/2013 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 01/2011
1	MetalsIBA 01/2020
1	Hypoxia-Inducible Factor 1IBA 10/2019
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	DioxinsIBA 01/2014
1	SoilIBA 01/2014
1	GATIBA 06/2013
1	Codon (Codons)IBA 06/2013
1	IronIBA 01/2012
1	CytokinesIBA 01/2012